The twelve lines we set for Vertiv and Amphenol on 27 October, read against their third-quarter 8-Ks and 10-Qs. Vertiv’s current deferred revenue went from $3,633.7 million to $4,120.5 million and its capex range rose to $575–600 million; it still files no backlog. Amphenol’s orders went from $10.7 billion to $12.2 billion, book-to-bill from 1.23 to 1.19, and it repaid its 364-day term loan.